Peripheral nerve elongation trial

Phase 1

• Conditions: Peripheral nerve disorder; Peripheral nerve gap; C26-240-30

• Registration Number: JPRN-jRCTs032180098
• Lead Sponsor: Yamazaki Masashi

Brief Summary

One patients had undergo this study. Prrimary outcome of this study was safety of the nerve lengthening methods. There were no adverse event.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-01-28
• Study Completion: 2021-09-08
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

Patients who injured peripheral nerve defect of limbs
20 years old or more and less than 65 years old

Exclusion Criteria

The diabetic patient who is under medication
The patient who have peripheral nerve disorder
The patient who has a serious heart disorder
The patient who has a doubt or diagnostic neoplastic lesion within 5 years before agreement
The woman that during the pregnancy or the pregnancy is doubted
The patient who received other study drugs within current 1 month.
The patient who has not ability for agreement with own will.
The patient who has not ability for agreement by the reading and writeing
The patient who has been judged to be inappropriate as a subject by the doctor incharge

Study & Design

• Study Type: Interventional
• Study Design: Not specified